| ||||||||||||||||
| ||||||||||||||||
— antitrust —Top tagsYou have executed a tag search on The Deal Newsweekly. To the right you will find a comprehensive list of stories tagged "antitrust." Below are the most-popular tags for The Deal Newsweekly. On the right of the page you will find a search box to dig deeper into our content.
Community
 Entries tagged "antitrust"Last hurrahNeelie Kroes will not go gently into the night as she aggressively clears the decks as EC competition commissioner only two months before the end of her term. A new map?The DOJ and FTC consider revised deal guidelines. Hit the booksA merger divestiture study would give antitrust agencies data to assess the value of requiring asset sales. An undiscovered countryJonathan Leibowitz's call to expand a rarely used provision of the FTC Act sparks alarm among business leaders. Cable unlimitedWriting with biting sarcasm, federal appeals judges last month struck down federal limits on how many subscribers one cable operator can serve. The FCC had capped the limit at 30%. Scenes from the slowdownM&A activity may have stalled during the first half of the year, but deal lawyers still had plenty to talk about. One annoying sweetheartThe FTC tries finally to end Generics' pay-for-delay Deals with branded pharma. But will it survive the healthcare reform? The 'pay for delay' debateFTC Chairman Jon Leibowitz has urged Congress to pass controversial legislation amending the antitrust laws to prohibit 'reverse payment' or 'pay for delay' patent settlements between branded and generic pharma companies. Good timesStrategic buyers looking to capitalize in the downturn should be well aware of antitrust issues they may face. Antitrust 2.0The return of tech dealmaking brings with it a revived threat of scrutiny. The return of 'big is bad'The authors take Christine Varney to task for rejecting a report on monopolization law. Antitrust's next frontier?The DOJ's new competition chief, Christine Varney, considers a stronger antitrust role in the financial sector. Antitrust internationalDawn of a new era: global cartel enforcement. New faces, new directionAntitrust mavens expect a more aggressive stance from the Department of Justice and the Federal Trade Commission. Time to thinkThe deal slowdown offers antitrust regulators an opportunity to rework merger guidelines. Queen of competitionIf confirmed as assistant attorney general, Christine Varney will need to resuscitate a demoralized antitrust unit. A new direction?President Obama's Department of Justice antitrust pick may signal a wave of change in merger enforcement. Two-track mindsWith the Whole Foods challenge, the FTC has aroused the anger of opponents of in-house trials. In Obama we antitrustAn examination of merger clearance under the new administration. Obama's antitrust revivalThe recession and struggling companies may hamstring the president-elect's ability to say no to mergers. Quality judgmentsAssessments of hospital care improvements are increasingly critical in merger assessments and for healthcare reform. In whom we antitrustIn a down economy, companies should prepare to defend against more antitrust litigation. Part 3, the next chapterThe FTC's campaign to resurrect in-house merger litigation revives a debate over fairness. Reconcilable differencesThe breakup of a hospital takeover shines a light on the controversial twists of the FTC merger review process. | ||||||||||||||||
|
|
|
|
|
